Combination therapy with parp inhibitor
    1.
    发明专利
    Combination therapy with parp inhibitor 审中-公开
    与PARP抑制剂组合治疗

    公开(公告)号:JP2013136605A

    公开(公告)日:2013-07-11

    申请号:JP2013024289

    申请日:2013-02-12

    Abstract: PROBLEM TO BE SOLVED: To provide a pharmaceutical composition of a PARP inhibitor shown to potentiate radiotherapy and chemotherapy by increasing apoptosis of cancer cells, limiting tumor growth, decreasing metastasis, and prolonging the survival of tumor-bearing animals.SOLUTION: The invention describes benzimidazole derivatives which constitute potent PARP inhibitors which is 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide, or a therapeutically acceptable salt thereof used in combination with radiotherapy, or in combination with other chemotherapeutic agents.

    Abstract translation: 要解决的问题:提供一种PARP抑制剂的药物组合物,其通过增加癌细胞的凋亡,限制肿瘤生长,减少转移和延长荷瘤动物的存活来增强放射治疗和化学疗法。解决方案:本发明描述了苯并咪唑 构成有效的PARP抑制剂的衍生物,其是2 - [(2R)-2-甲基吡咯烷-2-基] -1H-苯并咪唑-4-甲酰胺或其与放射治疗组合使用的治疗可接受的盐,或与其他化学治疗剂 代理商

Patent Agency Ranking